Search results
Results from the WOW.Com Content Network
The Regional Input–Output Modeling System (RIMS II) is a regional economic model developed and maintained by the US Bureau of Economic Analysis (BEA).. Regional input–output multipliers such as the RIMS II multipliers allow estimates of how a one-time or sustained increase in economic activity in a particular region will impact other industries located in the region—i.e., estimating ...
US Department of Commerce, Bureau of Economic Analysis . Regional multipliers: A user handbook for regional input–output modeling system (RIMS II). Third edition. Washington, D.C.: U.S. Government Printing Office. 1997. Eurostat Eurostat manual of supply, use and input-output tables.
Based on this data, multipliers are calculated and used to estimate economic impacts. [2] Examples of I/O models used for economic impact analyses are IMPLAN, [3] RIMS-II, [4] Chmura, [5] Emsi, [6] and aLocal Solutions. [7] Another method used for economic impact analyses are economic simulation models.
Commodity price shocks are considered to be a significant driving force of the US business cycle. [29] Along these lines, the research in [Trimbur, 2010, International Journal of Forecasting] shows empirical results for the relation between oil-prices and real GDP. The methodology uses a statistical model that incorporate level shifts in the ...
Meanwhile, Nordstrom on Tuesday topped expectations for quarterly profit on robust sales at its off-price banner. Kohl's quarterly comparable sales fell a bigger-than-expected 5.1%, and it now ...
This page was last edited on 18 March 2020, at 16:56 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may ...
Vionic Onyx Jamie Platform Sandals. $61 $130 Save $69. Every pair of shoes from Vionic has been specially designed by a team of podiatrists to provide the support and comfort you need for a full ...
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in patients ...